Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem paste with or without ubidecarenone/dexpanthenol/chlorhexidine cream for chronic anal fissure
2005-005675-15Phase 2Completed
- Sponsor
- Tecnimede
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of diltiazem, coenzyme q10, dexpanthenol and chlorhexidine in chronic anal fissure (CAF) (2 arms), sponsored by Tecnimede. Primary endpoint: CAF cure during 8-week treatment period. Started Aug 2008; status: completed.
02
Drugs
diltiazemcoenzyme q10dexpanthenolchlorhexidine
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on 2005-005675-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005675-15.